This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana's Arm to Open 10 Medical Centers to Serve Seniors
by Zacks Equity Research
Humana's (HUM) subsidiary to launch medical care centers at 10 more sites to take care of more seniors.
Humana, Accolade to Team Up for Providing Advanced Healthcare
by Zacks Equity Research
Humana (HUM) ties up with Accolade to meet healthcare needs of employers and their health plan members.
Why is it Worth Keeping Humana (HUM) in Your Portfolio Now?
by Zacks Equity Research
Riding high on robust Medicare business and strategic buyouts, Humana (HUM) looks promising to reap benefits for investors.
The Zacks Analyst Blog Highlights: Visa, Honeywell, Biogen, Humana and EOG Resources
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Honeywell, Biogen, Humana and EOG Resources
Top Stock Reports for Visa, Honeywell & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Honeywell (HON) and Biogen (BIIB).
Why Is Humana (HUM) Down 11.7% Since Last Earnings Report?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is UnitedHealth a Good Buy Despite Recent Regulatory Noise?
by Zacks Equity Research
The decline in UnitedHealth's (UNH) share price due to the recent legislative events, offers a good buying opportunity.
Universal Health's (UHS) Q4 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results gain from its healthy top-line growth.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
Big Q4 Numbers & New Trade Data
by Mark Vickery
Plenty of Q4 earnings numbers join new Manufacturing and Trade data, some of which had been previously delayed due to the government shutdown.
Humana's (HUM) Q4 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter earnings gain on the back of Medicare Advantage membership growth and operating efficiencies.
Humana (HUM) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 4.74% and 1.76%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What's in Store for Humana (HUM) Stock in Q4 Earnings?
by Zacks Equity Research
Higher enrollment and strong segmental results are expected to help Humana (HUM) in fourth-quarter earnings.
Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Humana (HUM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Humana (HUM) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HUM) Outperforming Other Medical Stocks This Year?
Why You Should Hold Mednax (MD) Stock in Your Portfolio
by Zacks Equity Research
Banking on top-line growth and strategic efforts, Mednax (MD) holds great potential to be a rewarding pick for investors.
Zacks.com featured highlights include: Humana, Darden, Sherwin-Williams, United Continental and Spirit Airlines
by Zacks Equity Research
Zacks.com featured highlights include: Humana, Darden, Sherwin-Williams, United Continental and Spirit Airlines
UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable
by Zacks Equity Research
UnitedHealth (UNH) shares gained following a strong fourth-quarter results, operating fundamentals point to a solid 2019
The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana
3 Reasons Why Growth Investors Shouldn't Overlook Humana (HUM)
by Zacks Equity Research
Humana (HUM) could produce exceptional returns because of its solid growth attributes.
5 Stocks With Upgraded Broker Ratings Worth Buying Right Now
by Zacks Equity Research
Following broker recommendation is the best and easiest way to pick stocks as brokers have a deeper insight of the overall sectors.
Top Ranked Growth Stocks to Buy for January 16th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 16th
UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results gain from higher revenues and membership.